Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS)
- PMID: 6685237
- DOI: 10.1212/wnl.33.11.1444
Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS)
Abstract
One method of evaluating the degree of neurologic impairment in MS has been the combination of grades (0 = normal to 5 or 6 = maximal impairment) within 8 Functional Systems (FS) and an overall Disability Status Scale (DSS) that had steps from 0 (normal) to 10 (death due to MS). A new Expanded Disability Status Scale (EDSS) is presented, with each of the former steps (1,2,3 . . . 9) now divided into two (1.0, 1.5, 2.0 . . . 9.5). The lower portion is obligatorily defined by Functional System grades. The FS are Pyramidal, Cerebellar, Brain Stem, Sensory, Bowel & Bladder, Visual, Cerebral, and Other; the Sensory and Bowel & Bladder Systems have been revised. Patterns of FS and relations of FS by type and grade to the DSS are demonstrated.
Similar articles
-
Historical and clinical perspectives of the expanded disability status scale.Neuroepidemiology. 2008;31(1):1-9. doi: 10.1159/000136645. Epub 2008 Jun 6. Neuroepidemiology. 2008. PMID: 18535394 Review.
-
Disability rating scales in multiple sclerosis.Ann N Y Acad Sci. 1984;436:347-60. doi: 10.1111/j.1749-6632.1984.tb14805.x. Ann N Y Acad Sci. 1984. PMID: 6598017
-
Scales for rating impairment in multiple sclerosis: a critique.Neurology. 1988 Nov;38(11):1793-8. doi: 10.1212/wnl.38.11.1793. Neurology. 1988. PMID: 3185917
-
On the origin of EDSS.Mult Scler Relat Disord. 2015 Mar;4(2):95-103. doi: 10.1016/j.msard.2015.02.003. Epub 2015 Feb 24. Mult Scler Relat Disord. 2015. PMID: 25787185 Review.
-
Clinical definition for multiple sclerosis treatment trials.Ann Neurol. 1994;36 Suppl:S73-9. doi: 10.1002/ana.410360717. Ann Neurol. 1994. PMID: 8017892 Review.
Cited by
-
No sex-specific difference in disease trajectory in multiple sclerosis patients before and after age 50.BMC Neurol. 2013 Jul 3;13:73. doi: 10.1186/1471-2377-13-73. BMC Neurol. 2013. PMID: 23822612 Free PMC article.
-
Multiple sclerosis and COVID-19: Assessing risk perception, patient behaviors and access to disease-modifying therapies.Mult Scler Relat Disord. 2022 Dec;68:104121. doi: 10.1016/j.msard.2022.104121. Epub 2022 Aug 17. Mult Scler Relat Disord. 2022. PMID: 36088727 Free PMC article.
-
Validation of patient determined disease steps (PDDS) scale scores in persons with multiple sclerosis.BMC Neurol. 2013 Apr 25;13:37. doi: 10.1186/1471-2377-13-37. BMC Neurol. 2013. PMID: 23617555 Free PMC article.
-
Combination of cyclosporine A with corticosteroids is effective for the treatment of neuromyelitis optica.J Neurol. 2013 Feb;260(2):627-34. doi: 10.1007/s00415-012-6692-2. Epub 2012 Oct 18. J Neurol. 2013. PMID: 23076828
-
An Abnormally High Neutrophil-to-Lymphocyte Ratio Is Not an Independent Outcome Predictor in AQP4-IgG-Positive NMOSD.Front Immunol. 2021 Feb 23;12:628024. doi: 10.3389/fimmu.2021.628024. eCollection 2021. Front Immunol. 2021. PMID: 33717149 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical